CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award CHIEF DEVELOPMENT OFFICER acquired 21,660 shares (grant or award)
- 4 Open-market sale Chief Accounting Officer sold 604 shares at $17.50 ($10,570)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 2,640 shares at $17.50 ($46,200)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Director acquired 6,000 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 17,340 shares (grant or award)
- 4 Open-market sale Chief Business Officer sold 2,643 shares at $17.50 ($46,253)
- 4 Grant or award Chief Financial Officer acquired 12,000 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 2,643 shares at $17.50 ($46,253)
- 4 Open-market sale Chief Technology Officer sold 2,643 shares at $17.50 ($46,253)
- 4 Open-market sale Chief Executive Officer sold 8,703 shares at $17.50 ($152,303)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 15 of 33 · 660 filings